-
U.S. Supreme Court rejects Teva challenge to $235M GSK award in patent dispute over generic drugs involving Coreg
The case involves "skinny labels," which allow generic drugmakers to avoid patent lawsuits if a generic drug's label omits potentially infringing uses of a brand-name drug, per a Reuters report.